Small-caps poised to outperform thanks to biotechs, regional banks and reshoring
Mike Rode, senior investment director at American Century Investments, sits down with InvestmentNews anchor Gregg Greenberg to explain why small-caps are set to outperform due to the rise of reshoring, new IPOs and biotechs.
